Real-time detection of gene expression in cancer cells using molecular beacon imaging: New strategies for cancer research

Cancer Research

Volumn 65, Issue 5, 2005, Pages 1909-1917

  Peng, Xiang Hong ^a   Cao, Ze Hong ^a   Xia, Jin Tang ^c   Carlson, Grant W ^a   Lewis, Melinda M ^b   Wood, William C ^a   Yang, Lily ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Guang Zhou University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DOCETAXEL; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; PROTEIN P53; SURVIVIN;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER RESEARCH; CELL VIABILITY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMAGING SYSTEM; MOLECULAR BEACON; OLIGONUCLEOTIDE PROBE; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; FEMALE; FLUORESCENT DYES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16444382036     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3196     Document Type: Article

References (24)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Dickson RB, Lippman ME. Cancer of the breast. Molecular biology of breast cancer. In: DeVita VTJ, Helman S, Rosenberg SA, editors. Principles and practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1633-45.
3. Nathanson KL, Wooster R, Weber BL, Nathanson KN. Breast cancer genetics: what we know and what we need. Nat Med 2001;7:552-6.
4. Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996;14:303-8.
5. Bonnet G, Tyagi S, Libchaber A, Kramer FR. Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc Natl Acad Sci U S A 1999;96:6171-6.
6. Tan W, Fang X, Li J, Liu X. Molecular beacons: a novel DNA probe for nucleic acid and protein studies. Chemistry 2000;6:1107-11.
7. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 1998;16:49-53.
8. Heyduk T, Heyduk E. Molecular beacons for detecting DNA binding proteins. Nat Biotechnol 2002;20:171-6.
9. Sokol DL, Zhang X, Lu P, Gewirtz AM. Real time detection of DNA. RNA hybridization in living cells. Proc Natl Acad Sci U S A 1998;95:11538-43.
10. Dirks RW, Molenaar C, Tanke HJ. Methods for visualizing RNA processing and transport pathways in living cells. Histochem Cell Biol 2001;115:3-11.
11. Fang X, Mi Y, Li JJ, Beck T, Schuster S, Tan W. Molecular beacons: fluorogenic probes for living cell study. Cell Biochem Biophys 2002;37:71-81.
12. Bratu DP, Cha BJ, Mhlanga MM, Kramer FR, Tyagi S. Visualizing the distribution and transport of mRNAs in living cells. Proc Natl Acad Sci U S A 2003;100:13308-13.
13. Shah R, El-Deiry WS. p53-Dependent activation of a molecular beacon in tumor cells following exposure to doxorubicin chemotherapy. Cancer Biol Ther 2004;3:871-5.
14. Perlette J, Tan W. Real-time monitoring of intracellular mRNA hybridization inside single living cells. Anal Chem 2001;73:5544-50.
15. Weinstat-Saslow D, Merino MJ, Manrow RE, et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med 1995;1:1257-60.
16. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000;6:127-34.
17. Altieri DC. Survivin and apoptosis control. Adv Cancer Res 2003;88:31-52.
18. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001;7:542-7.
19. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003;63:6815-24.
20. Favaloro EJ, Moraitis N, Bradstock K, Koutts J. Co-expression of haemopoietic antigens on vascular endothelial cells: a detailed phenotypic analysis. Br J Haematol 1990;74:385-94.
21. Ling X, Bernacki RJ, Brattain MG, Li F. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest. J Biol Chem 2004;279:15196-203.
22. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy, M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002;277:3247-57.
23. Rizzo J, Gifford L, Zhang X, Gewirtz A, Lu P. Chimeric RNA-DNA molecular beacon assay for ribonuclease H activity. Mol Cell Probes 2002;16:277-83.
24. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature (Lond) 2000;406:747-52.